Luis Fernando de Oliveira Gorla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luis Fernando de Oliveira Gorla has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Valfrido Antonio Pereira-Filho
Department of Diagnosis and Surgery, School of Dentistry Araraquara, São Paulo State University (UNESP), Araraquara 14801-903, SP, Brazil
5 shared publications - Eduardo Hochuli-Vieira
Department of Diagnostic and Surgery, Araraquara School of Dentistry, São Paulo State University (UNESP), São Paulo, Brazil
4 shared publications - Rodrigo dos Santos Pereira
Department of Oral and Maxillofacial Surgery Universidade Federal do Rio de Janeiro Rio de Janeiro Brazil
4 shared publications - Federica Sobrero
Division of Maxillofacial Surgery, Città della Salute e della Scienza Hospital, University of Turin, Turin, Italy
3 shared publications - Roberta Okamoto
Department of Basic Sciences, School of Dentistry, São Paulo State University (UNESP), Araçatuba, Brazil
3 shared publications - Sahand Samieirad
Department of Oral & Maxillofacial Surgery, Faculty of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publications
Latest Publications
- 31 August 2026
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
Simultaneous Paranasal Augmentation and Le Fort I Osteotomy Using a Patient-Specific Implant Designed to Share the Fixation Space: Two-Year Clinical Outcomes
Background: Residual paranasal concavity may persist after Le Fort I osteotomy despite adequate maxillary repositioning, limiting the aesthetic impact of orthognathic surgery. Simultaneous paranasal implant placement is rarely reported due to spatial conflict with rigid internal fixation systems and concerns regarding infraorbital nerve safety. Methods: Two patients underwent Le Fort I osteotomy combined with simultaneous placement of patient-specific paranasal implants designed through 3-dimensional virtual surgical planning (VSP) to intentionally share the anatomical space occupied by Le Fort I fixation plates. Implants were fabricated from polymethyl methacrylate (PMMA) using CAD/CAM patient-specific molds. Clinical and photographic outcomes were assessed at minimum 24-month follow-up. Results: Both patients achieved satisfactory midface projection with no postoperative complications at 24-month follow-up. No implant displacement, infraorbital nerve deficit, wound dehiscence, or plate removal was required in either case. Conclusion: A patient-specific paranasal implant designed to coexist with Le Fort I fixation hardware enables safe, effective, and stable single-stage midface augmentation during orthognathic surgery, eliminating secondary procedures over a minimum 2-year follow-up.
- 31 August 2026
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
Simultaneous Paranasal Augmentation and Le Fort I Osteotomy Using a Patient-Specific Implant Designed to Share the Fixation Space: Two-Year Clinical Outcomes
Background: Residual paranasal concavity may persist after Le Fort I osteotomy despite adequate maxillary repositioning, limiting the aesthetic impact of orthognathic surgery. Simultaneous paranasal implant placement is rarely reported due to spatial conflict with rigid internal fixation systems and concerns regarding infraorbital nerve safety. Methods: Two patients underwent Le Fort I osteotomy combined with simultaneous placement of patient-specific paranasal implants designed through 3-dimensional virtual surgical planning (VSP) to intentionally share the anatomical space occupied by Le Fort I fixation plates. Implants were fabricated from polymethyl methacrylate (PMMA) using CAD/CAM patient-specific molds. Clinical and photographic outcomes were assessed at minimum 24-month follow-up. Results: Both patients achieved satisfactory midface projection with no postoperative complications at 24-month follow-up. No implant displacement, infraorbital nerve deficit, wound dehiscence, or plate removal was required in either case. Conclusion: A patient-specific paranasal implant designed to coexist with Le Fort I fixation hardware enables safe, effective, and stable single-stage midface augmentation during orthognathic surgery, eliminating secondary procedures over a minimum 2-year follow-up.
- Open Access
- 5 February 2025
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 53 (5) , 590-595
Multicentre retrospective study on plate osteosynthesis for non-condylar mandibular fractures in paediatric patients with deciduous, mixed, and permanent dentition: A World Oral Maxillofacial Trauma (WORMAT) project
- 5 February 2025
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 53 (5) , 590-595
Open AccessMulticentre retrospective study on plate osteosynthesis for non-condylar mandibular fractures in paediatric patients with deciduous, mixed, and permanent dentition: A World Oral Maxillofacial Trauma (WORMAT) project
- Open Access
- 14 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (18) , 5455
Management of Mandibular Condyle Fractures in Pediatric Patients: A Multicentric Retrospective Study with 180 Children and Adolescents
Background: Mandibular condyle fractures in pediatric patients can lead to crippling sequelae such as ankylosis, pain and facial deformity if not managed properly. However, there is no consensus on the best approach for treating these fractures in children. Objective: This study aimed to describe the management of mandibular condyle fractures in growing patients across 14 maxillofacial departments worldwide. Methods: A retrospective multicenter study was conducted on children and adolescents aged 0 to 16 who had at least one mandibular condyle fracture. This study included patients who underwent expectant, closed, or open management and were treated over an 11-year period. Results: 180 patients had at least one mandibular condyle fracture, and 37 had a second condylar fracture. One hundred sixteen patients (65%) were males, and 64 (35%) were females (ratio 1.8:1). An expectant strategy was chosen in 51 (28%) patients, a closed treatment—stand-alone maxillomandibular fixation (MMF)—in 47 (26%), and open reduction and internal fixation (ORIF) was performed in 82 (46%) patients. The management varied significantly between the different departments (p < 0.0001). Significant differences were also identified between the fracture type (non-displaced, displaced or comminuted) and the management of the 180 patients with a single condylar fracture. Out of 50 non-displaced fractures, only 3 (6%) had ORIF, 25 (50%) had expectant management, and 22 (44%) had MMF. Out of 129 displaced fractures, 79 (62%) had ORIF, 25 (19%) had a soft diet, and 25 (19%) had MMF. Conclusions: Expectative management, MMF, and ORIF were all effective in treating pediatric mandibular condyle fractures, with a low incidence of complications and asymmetry.
- 14 September 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (18) , 5455
Open AccessManagement of Mandibular Condyle Fractures in Pediatric Patients: A Multicentric Retrospective Study with 180 Children and Adolescents
Background: Mandibular condyle fractures in pediatric patients can lead to crippling sequelae such as ankylosis, pain and facial deformity if not managed properly. However, there is no consensus on the best approach for treating these fractures in children. Objective: This study aimed to describe the management of mandibular condyle fractures in growing patients across 14 maxillofacial departments worldwide. Methods: A retrospective multicenter study was conducted on children and adolescents aged 0 to 16 who had at least one mandibular condyle fracture. This study included patients who underwent expectant, closed, or open management and were treated over an 11-year period. Results: 180 patients had at least one mandibular condyle fracture, and 37 had a second condylar fracture. One hundred sixteen patients (65%) were males, and 64 (35%) were females (ratio 1.8:1). An expectant strategy was chosen in 51 (28%) patients, a closed treatment—stand-alone maxillomandibular fixation (MMF)—in 47 (26%), and open reduction and internal fixation (ORIF) was performed in 82 (46%) patients. The management varied significantly between the different departments (p < 0.0001). Significant differences were also identified between the fracture type (non-displaced, displaced or comminuted) and the management of the 180 patients with a single condylar fracture. Out of 50 non-displaced fractures, only 3 (6%) had ORIF, 25 (50%) had expectant management, and 22 (44%) had MMF. Out of 129 displaced fractures, 79 (62%) had ORIF, 25 (19%) had a soft diet, and 25 (19%) had MMF. Conclusions: Expectative management, MMF, and ORIF were all effective in treating pediatric mandibular condyle fractures, with a low incidence of complications and asymmetry.
- 3 July 2024
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 62 (8) , 729-735
Guided versus non-guided chin repositioning: a retrospective study on accuracy
- 3 July 2024
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 62 (8) , 729-735
Guided versus non-guided chin repositioning: a retrospective study on accuracy
- 25 May 2022
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 60 (8) , 1125-1130
In vitro mechanical test of grid plates for mandibular angle fractures
- 25 May 2022
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 60 (8) , 1125-1130
In vitro mechanical test of grid plates for mandibular angle fractures
- Open Access
- 7 April 2022
- Published by Wiley in Dental Traumatology
- Vol. 38 (3) , 196-205
A multicentric, prospective study on oral and maxillofacial trauma in the female population around the world
Background/Aims: Approximately 20% of patients with maxillofacial trauma are women, but few articles have analysed this. The aim of this multicentric, prospective, epidemiological study was to analyse the characteristics of maxillofacial fractures in the female population managed in 14 maxillofacial surgery departments on five continents over a 1‐year period.Methods: The following data were collected: age (0–18, 19–64, or ≥65 years), cause and mechanism of the maxillofacial fracture, alcohol and/or drug abuse at the time of trauma, fracture site, Facial Injury Severity Scale score, associated injury, day of trauma, timing and type of treatment, and length of hospitalization.Results: Between 30 September 2019 and 4 October 2020, 562 of 2387 patients hospitalized with maxillofacial trauma were females (24%; M: F ratio, 3.2:1) aged between 1 and 96 years (median age, 37 years). Most fractures occurred in patients aged 20–39 years. The main causes were falls (43% [median age, 60.5 years]), which were more common in Australian, European and American units (p < .001). They were followed by road traffic accidents (35% [median age, 29.5 years]). Assaults (15% [median age, 31.5 years]) were statistically associated with alcohol and/or drug abuse (p < .001). Of all patients, 39% underwent open reduction and internal fixation, 36% did not receive surgical treatment, and 25% underwent closed reduction.Conclusion: Falls were the main cause of maxillofacial injury in the female population in countries with ageing populations, while road traffic accidents were the main cause in African and some Asian centres, especially in patients ≤65 years. Assaults remain a significant cause of trauma, primarily in patients aged 19–64 years, and they are related to alcohol use.
- 7 April 2022
- Published by Wiley in Dental Traumatology
- Vol. 38 (3) , 196-205
Open AccessA multicentric, prospective study on oral and maxillofacial trauma in the female population around the world
Background/Aims: Approximately 20% of patients with maxillofacial trauma are women, but few articles have analysed this. The aim of this multicentric, prospective, epidemiological study was to analyse the characteristics of maxillofacial fractures in the female population managed in 14 maxillofacial surgery departments on five continents over a 1‐year period.Methods: The following data were collected: age (0–18, 19–64, or ≥65 years), cause and mechanism of the maxillofacial fracture, alcohol and/or drug abuse at the time of trauma, fracture site, Facial Injury Severity Scale score, associated injury, day of trauma, timing and type of treatment, and length of hospitalization.Results: Between 30 September 2019 and 4 October 2020, 562 of 2387 patients hospitalized with maxillofacial trauma were females (24%; M: F ratio, 3.2:1) aged between 1 and 96 years (median age, 37 years). Most fractures occurred in patients aged 20–39 years. The main causes were falls (43% [median age, 60.5 years]), which were more common in Australian, European and American units (p < .001). They were followed by road traffic accidents (35% [median age, 29.5 years]). Assaults (15% [median age, 31.5 years]) were statistically associated with alcohol and/or drug abuse (p < .001). Of all patients, 39% underwent open reduction and internal fixation, 36% did not receive surgical treatment, and 25% underwent closed reduction.Conclusion: Falls were the main cause of maxillofacial injury in the female population in countries with ageing populations, while road traffic accidents were the main cause in African and some Asian centres, especially in patients ≤65 years. Assaults remain a significant cause of trauma, primarily in patients aged 19–64 years, and they are related to alcohol use.
- 1 November 2017
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 28 (8) , 2036-2037
Endoscopic Removal of Displaced Sagittal Intracapsular Condylar Fracture
Fractures involving the mandibular condyle are among the most common fractures of facial bones and still generate great discussion concerning therapeutic issues. Several factors have influence on the decision of treatment management of these fractures. In some patients, even when there is displacement of fractured fragments, the choice for conservative treatment is made. However, the removal of the condyle fragment may be required. In the oral surgery scope, endoscopy is a procedure used in many areas, and can be helpful to improve the visualization of surgical sites with difficult access. The endoscopic surgery brings benefits to patient such as no scar or minimal scar, lower risk to nerve damage, and decreased of surgical trauma and bleeding. In addition, according to surgeon experience, the surgery may become more dynamic. The aim of this study is to present an endoscopic technique associated with a transoral approach to remove a displaced sagittal intracapsular condyle fragment. Furthermore, to expose the advantages and benefits of this technique as well as the satisfactory results achieved.
- 1 November 2017
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 28 (8) , 2036-2037
Endoscopic Removal of Displaced Sagittal Intracapsular Condylar Fracture
Fractures involving the mandibular condyle are among the most common fractures of facial bones and still generate great discussion concerning therapeutic issues. Several factors have influence on the decision of treatment management of these fractures. In some patients, even when there is displacement of fractured fragments, the choice for conservative treatment is made. However, the removal of the condyle fragment may be required. In the oral surgery scope, endoscopy is a procedure used in many areas, and can be helpful to improve the visualization of surgical sites with difficult access. The endoscopic surgery brings benefits to patient such as no scar or minimal scar, lower risk to nerve damage, and decreased of surgical trauma and bleeding. In addition, according to surgeon experience, the surgery may become more dynamic. The aim of this study is to present an endoscopic technique associated with a transoral approach to remove a displaced sagittal intracapsular condyle fragment. Furthermore, to expose the advantages and benefits of this technique as well as the satisfactory results achieved.
- 1 November 2017
- Published by Quintessence Publishing in International Journal of Periodontics & Restorative Dentistry
- Vol. 37 (6) , e321-e327
Maxillary Sinus Elevation Surgery with ChronOS and Autogenous Bone Graft: Immunohistochemical Assessment of RUNX2, VEGF, TRAP, and Osteocalcin
Rodrigo dos Santos Pereira, DDS, MSc, PhD/Fernanda Brasil Jorge Daura Boos, DDS, MSc, PhD/Luis Fernado Gorla, DDS/Idelmo Rangel Garcia Jr, DDS, MSc, PhD/Roberta Okamoto, DDS, MSc, PhD/Eduardo Hochuli-Vieira, DDS, MSc, PhD: The purpose of this study was to evaluate a composite graft of ChronOS, a betatricalcium phosphate (β-TCP), mixed 1:1 with an autogenous bone graft in human maxillary sinus augmentation. A total of 12 maxillary sinuses were grafted with an autogenous bone graft (control group), and 9 maxillary sinuses were grafted with ChronOS mixed 1:1 with an autogenous bone graft (test group). After 6 months, biopsy samples were obtained concurrent to the placement of dental implants and were subjected to histomorphometric and immunohistochemical analyses for Runt-related transcription factor 2 (RUNX2), vascular endothelial growth factor (VEGF), tartrate-resistant acid phosphatase, and osteocalcin. Histologic analysis of samples obtained from the test group revealed the presence of immature bone, while samples from the control group indicated lamellar bone formation. However, both types of bone grafts were well vascularized. The new bone formation averaged 25.4% ? 6.4% in the test group and 38.6% ? 10.5% in the control group (P = .001). Immunostaining of samples in the test group showed high cellular turnover. The outcomes of this study demonstrate a delay in bone formation but intense cellular differentiation after 6 months of bone graft healing in the test group. The amount of immature bone and the immunostaining for RUNX2 and VEGF provide evidence of an osteogenic pathway that can improve the bone formation rate.
- 1 November 2017
- Published by Quintessence Publishing in International Journal of Periodontics & Restorative Dentistry
- Vol. 37 (6) , e321-e327
Maxillary Sinus Elevation Surgery with ChronOS and Autogenous Bone Graft: Immunohistochemical Assessment of RUNX2, VEGF, TRAP, and Osteocalcin
Rodrigo dos Santos Pereira, DDS, MSc, PhD/Fernanda Brasil Jorge Daura Boos, DDS, MSc, PhD/Luis Fernado Gorla, DDS/Idelmo Rangel Garcia Jr, DDS, MSc, PhD/Roberta Okamoto, DDS, MSc, PhD/Eduardo Hochuli-Vieira, DDS, MSc, PhD: The purpose of this study was to evaluate a composite graft of ChronOS, a betatricalcium phosphate (β-TCP), mixed 1:1 with an autogenous bone graft in human maxillary sinus augmentation. A total of 12 maxillary sinuses were grafted with an autogenous bone graft (control group), and 9 maxillary sinuses were grafted with ChronOS mixed 1:1 with an autogenous bone graft (test group). After 6 months, biopsy samples were obtained concurrent to the placement of dental implants and were subjected to histomorphometric and immunohistochemical analyses for Runt-related transcription factor 2 (RUNX2), vascular endothelial growth factor (VEGF), tartrate-resistant acid phosphatase, and osteocalcin. Histologic analysis of samples obtained from the test group revealed the presence of immature bone, while samples from the control group indicated lamellar bone formation. However, both types of bone grafts were well vascularized. The new bone formation averaged 25.4% ? 6.4% in the test group and 38.6% ? 10.5% in the control group (P = .001). Immunostaining of samples in the test group showed high cellular turnover. The outcomes of this study demonstrate a delay in bone formation but intense cellular differentiation after 6 months of bone graft healing in the test group. The amount of immature bone and the immunostaining for RUNX2 and VEGF provide evidence of an osteogenic pathway that can improve the bone formation rate.
- 1 January 2017
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 28 (1) , 227-230
Off-Label Use of Bone Morphogenetic Protein 2 in the Reconstructions of Mandibular Continuity Defects
This paper describes 3 patients of off-label use of bone morphogenetic protein 2 (rhBMP-2) in the reconstruction of mandibular continuity defects. In the first patient, rhBMP-2 was associated with iliac crest bone graft for late mandibular reconstruction after resection of osteosarcoma. In the 2 other patients, rhBMP-2 was used alone. In 1 patient the mandibular continuity defect was due to resection for treatment of osteomyelitis and in the other patient a continuity defect was created by unsuccessful osteogenic distraction for correction of mandibular hypoplasia. Despite the good results in those patients, the off-label use of rhBMP-2 is associated with increased rate of complications, so more studies are needed to assess the predictability of the use of rhBMP-2 in mandibular continuity defects. Therefore, at the moment the off-label use of rhBMP-2 should be restricted to complicated bone defects in which the conventional alternatives of reconstruction were unsuccessful.
- 1 January 2017
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 28 (1) , 227-230
Off-Label Use of Bone Morphogenetic Protein 2 in the Reconstructions of Mandibular Continuity Defects
This paper describes 3 patients of off-label use of bone morphogenetic protein 2 (rhBMP-2) in the reconstruction of mandibular continuity defects. In the first patient, rhBMP-2 was associated with iliac crest bone graft for late mandibular reconstruction after resection of osteosarcoma. In the 2 other patients, rhBMP-2 was used alone. In 1 patient the mandibular continuity defect was due to resection for treatment of osteomyelitis and in the other patient a continuity defect was created by unsuccessful osteogenic distraction for correction of mandibular hypoplasia. Despite the good results in those patients, the off-label use of rhBMP-2 is associated with increased rate of complications, so more studies are needed to assess the predictability of the use of rhBMP-2 in mandibular continuity defects. Therefore, at the moment the off-label use of rhBMP-2 should be restricted to complicated bone defects in which the conventional alternatives of reconstruction were unsuccessful.